Glial cell line-derived neurotrophic factor gene delivery via a polyethylene imine grafted chitosan carrier

Yu-Shiang Peng,^1,* Po-Liang Lai,^2,* Sydney Peng,¹ His-Chin Wu,³ Siang Yu,¹ Tsan-Yun Tseng,⁴ Li-Fang Wang,⁵ I-Ming Chu<sup>1

1</sup>Department of Chemical Engineering, National Tsing Hua University, Hsinchu, ²Department of Orthopedic Surgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, ³Department of Materials Engineering, Tatung University, Taipei, ⁴Graduate School of Biotechnology and Bioengineering, College of Engineering, Yuan Ze University, Chung-Li, ⁵Department of Medicinal and Applied Chemistry, Kaohsiung Medical University, Kaohsiung, Taiwan

*Yu-Shiang Peng and Po-Liang Lai contributed equally to this work

Abstract: Parkinson’s disease is known to result from the loss of dopaminergic neurons. Direct intracerebral injections of high doses of recombinant glial cell line-derived neurotrophic factor (GDNF) have been shown to protect adult nigral dopaminergic neurons. Because GDNF does not cross the blood–brain barrier, intracerebral gene transfer is an ideal option. Chitosan (CHI) is a naturally derived material that has been used for gene transfer. However, the low water solubility often leads to decreased transfection efficiency. Grafting of highly water-soluble polyethylene imines (PEI) and polyethylene glycol onto polymers can increase their solubility. The purpose of this study was to design a non-viral gene carrier with improved water solubility as well as enhanced transfection efficiency for treating Parkinsonism. Two molecular weights (Mw =600 and 1,800 g/mol) of PEI were grafted onto CHI (PEI600-g-CHI and PEI1800-g-CHI, respectively) by opening the epoxide ring of ethylene glycol diglycidyl ether (EX-810). This modification resulted in a non-viral gene carrier with less cytotoxicity. The transfection efficiency of PEI600-g-CHI/deoxyribonucleic acid (DNA) polyplexes was significantly higher than either PEI1800-g-CHI/DNA or CHI/DNA polyplexes. The maximal GDNF expression of PEI600-g-CHI/DNA was at the polymer:DNA weight ratio of 10:1, which was 1.7-fold higher than the maximal GDNF expression of PEI1800-g-CHI/DNA. The low toxicity and high transfection efficiency of PEI600-g-CHI make it ideal for application to GDNF gene therapy, which has potential for the treatment of Parkinson’s disease.

Keywords: chitosan, gene transfection, glial cell, Parkinson’s disease, polyethylene imine

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.